| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry knockout validation; human; 1 ug/ml; loading ...; fig 1a
- western blot knockout validation; human; 0.2 ug/ml; loading ...; fig 1a
| Sola M, Magrin C, Pedrioli G, Pinton S, Salvade A, Papin S, et al. Tau affects P53 function and cell fate during the DNA damage response. Commun Biol. 2020;3:245 pubmed publisher |
- immunohistochemistry; human; 1:500; loading ...; fig 1d
| Liu Y, Zhang S, Li X, Liu E, Wang X, Zhou Q, et al. Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier. Biosci Rep. 2020;40: pubmed publisher |
| Nobuhara C, DeVos S, Commins C, Wegmann S, Moore B, Roe A, et al. Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro. Am J Pathol. 2017;187:1399-1412 pubmed publisher |
- western blot; human; fig 3a
| Taoka R, Jinesh G, Xue W, Safe S, Kamat A. CF3DODA-Me induces apoptosis, degrades Sp1, and blocks the transformation phase of the blebbishield emergency program. Apoptosis. 2017;22:719-729 pubmed publisher |
- western blot; human; loading ...; fig 1a
| Jinesh G, Molina J, Huang L, Laing N, Mills G, Bar Eli M, et al. Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis. Cell Death Discov. 2016;2:16003 pubmed publisher |
- immunocytochemistry; human; 1:1000; fig 8
| Winiecka Klimek M, Smolarz M, Walczak M, Zieba J, Hulas Bigoszewska K, Kmieciak B, et al. SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence. PLoS ONE. 2015;10:e0141688 pubmed publisher |
- western blot; human; fig 3
| Chu T, Li Q, Qiu T, Sun Z, Hu Z, Chen Y, et al. Clearance of the intracellular high level of the tau protein directed by an artificial synthetic hydrolase. Mol Biosyst. 2014;10:3081-5 pubmed publisher |
| Di Primio C, Quaranta P, Mignanelli M, Siano G, Bimbati M, Scarlatti A, et al. Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons. PNAS Nexus. 2023;2:pgad282 pubmed publisher |
| Liu G, Fiock K, Levites Y, Golde T, Hefti M, Lee G. Fyn depletion ameliorates tauP301L-induced neuropathology. Acta Neuropathol Commun. 2020;8:108 pubmed publisher |
| Sud R, Geller E, Schellenberg G. Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies. Mol Ther Nucleic Acids. 2014;3:e180 pubmed publisher |
| Gu G, Wu D, Lund H, Sunnemark D, Kvist A, Milner R, et al. Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease. J Alzheimers Dis. 2013;33:699-713 pubmed publisher |
